Abstract:To develop a new interventional oncology technique, "radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus thymidine kinase (GFP/HSV-TK)/ganciclovir (GCV) gene therapy of cholangiocarcinoma." Luciferase/mCherry-labeled cholangiocarcinoma cells and 24 mice with subcutaneously implanted cholangiocarcinoma cells were treated by: (i) a combination of green fluorescent protein (GFP)/HSV-TK/plasmid gene transfection followed by RFH and ganciclovir exposure; (ii) gene therapy alone; (iii) RFH alone; and (iv) phosphate-buffered saline (PBS) to serve as a control (6 mice per group). Cell viabilities were quantified by MTS assay. Bioluminescent optical imaging and transcutaneous ultrasound imaging were used to follow up the tumor growth over 2 weeks. For in-vivo technical validation of the new technique, pigs in two groups received either intrabiliary delivery of GFP/HSV-TK/plasmid using a needle-integrated balloon catheter flowed by RFH enhancement (n = 6) or gene delivery only (n = 6). GFP signal in bile duct walls were quantified by optical imaging.The non- parametric Mann-Whitney U test was used for statistical comparison of variables. MTS assay demonstrated the lowest cell proliferation in combination therapy compared with three control groups (24.0 ± 5.3% vs 41.9 ± 6.4% vs 72.0 ± 9.0% vs 100%, p<0.001). GFP optical imaging confirmed that GFP/HSV-TK gene expression peaked at day 2 after gene transfection. Bioluminescent optical imaging demonstrated the decreased bioluminescence signals in tumors of combination therapy, compared with other control groups (0.71 ± 0.16 vs 1.46 ± 0.21 vs 2.10 ± 0.27 vs 2.36 ± 0.28, p<0.001). Ultrasound imaging showed the smallest tumor volumes of the combination therapy group, compared with other groups (0.90 ± 0.21 VS 1.61 ± 0.21 VS 2.22 ± 0.25 VS 2.50 ± 0.30, p<0.001). optical imaging confirmed higher GFP expression in the bile ducts with RFH enhancement (signal to noise ratio: 1.28 ± 0.61 VS 0.49 ± 0.31, P<0.05). It is feasible to use intratumoral RFH to enhance GFP/HSV-TK/plasmid gene expression and HSV-TK/GCV gene therapy of cholangiocarcinomas.This concept may pave a new avenue for managing pancreatobiliary malignancies.(supported by an NIH RO1EBO12467)

Adenovirus-mediated gene transfer of tissue factor pathway inhibitor-2 inhibits gallbladder carcinoma growth in vitro and in vivo.

[The Role of Tissue Factor Pathway Inhibitor-2 Gene in Gallbladder Cancer].

Betulinic acid induces apoptosis of gallbladder cancer cells via repressing SCD1.

Downregulated Expression of Hepatoma-Derived Growth Factor (HDGF) Reduces Gallbladder Cancer Cell Proliferation and Invasion

Mir-143-3p Targeting of ITGA6 Suppresses Tumour Growth and Angiogenesis by Downregulating PLGF Expression Via the PI3K/AKT Pathway in Gallbladder Carcinoma

Intrabiliary Radiofrequency Heating-Enhanced Direct Intratumoral GFP/HSV-TK Gene Therapy of Cholangiocarcinoma: A Preclinical Study on Mice and Pigs

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment

Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway

Growth Inhibition and Apoptosis Induced by Adenovirus Mediated MDA-7/IL-24 Gene in Gallbladder Carcinoma of Nude Mice

The Inhibitory Effects of Deleted in Liver Cancer 1 Gene on Gallbladder Cancer Growth Through Induction of Cell Cycle Arrest and Apoptosis

KIF15 Knockdown Suppresses Gallbladder Cancer Development.

Bcl-2 Gene Silencing by RNA Interference Inhibits the Growth of the Human Gallbladder Carcinoma Cell Line GBC-SD in Vitro and in Vivo

Inhibition of Lung Cancer by Transfer Ofp53 Gene Using Tie2-mediated Gene Delivery System

Microrna-30a-5p Inhibits Gallbladder Cancer Cell Proliferation, Migration And Metastasis By Targeting E2f7

20(S)-Ginsenoside Rg3 Promotes Senescence And Apoptosis In Gallbladder Cancer Cells Via The P53 Pathway

Downregulation of TPTE2P1 Inhibits Migration and Invasion of Gallbladder Cancer Cells

Uhrf1 Depletion Suppresses Growth of Gallbladder Cancer Cells Through Induction of Apoptosis and Cell Cycle Arrest

FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

The Construction of Gallbladder Carcinoma Cell Line GBC-SD with Stable Expression of DMBT1 and Its Growth Properties HE Too

Tea Polyphenols Induce S Phase Arrest and Apoptosis in Gallbladder Cancer Cells.